Preclinical data suggest that overexpression of the vitamin D receptor (VDR) may interact with the RAS-MAPK and PI3K-AKT pathways in colorectal cancer, supporting the potential for chemoprevention strategies targeting VDR (121). This evidence concerns the gene PIK3CA and colorectal cancer.